Efficacy of Carraguard-based microbicides in vivo despite variable in vitro activity.
Anti-HIV microbicides are being investigated in clinical trials and understanding how promising strategies work, coincident with demonstrating efficacy in vivo, is central to advancing new generation microbicides. We evaluated Carraguard and a new generation Carraguard-based formulation containing t...
Main Authors: | Stuart G Turville, Meropi Aravantinou, Todd Miller, Jessica Kenney, Aaron Teitelbaum, Lieyu Hu, Anne Chudolij, Tom M Zydowsky, Michael Piatak, Julian W Bess, Jeffrey D Lifson, James Blanchard, Agegnehu Gettie, Melissa Robbiani |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2008-09-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2525816?pdf=render |
Similar Items
-
A macaque model to study vaginal HSV-2/immunodeficiency virus co-infection and the impact of HSV-2 on microbicide efficacy.
by: Federica Crostarosa, et al.
Published: (2009-11-01) -
Acceptability of Carraguard vaginal microbicide gel among HIV-infected women in Chiang Rai, Thailand.
by: Sara J Whitehead, et al.
Published: (2011-01-01) -
An antiretroviral/zinc combination gel provides 24 hours of complete protection against vaginal SHIV infection in macaques.
by: Jessica Kenney, et al.
Published: (2011-01-01) -
A tonsillar PolyICLC/AT-2 SIV therapeutic vaccine maintains low viremia following antiretroviral therapy cessation.
by: Panagiotis Vagenas, et al.
Published: (2010-09-01) -
A potent combination microbicide that targets SHIV-RT, HSV-2 and HPV.
by: Larisa Kizima, et al.
Published: (2014-01-01)